Suppr超能文献

验证良性腮腺肿瘤行眼球摘除术的适应证。

Validation of indications for enucleation for benign parotid gland tumors.

机构信息

Department of Otolaryngology, Tenri Hospital, Nara, Japan.

Department of Otolaryngology, Head and Neck Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

出版信息

Head Neck. 2023 Apr;45(4):931-938. doi: 10.1002/hed.27321. Epub 2023 Feb 17.

Abstract

BACKGROUND

Enucleation has been reported as a minimally invasive surgery for Warthin's tumor (WT). However, the definite indications for enucleation have not been clarified.

METHODS

Enucleation was indicated by the following findings: findings of WT, cystic fluid, or benign leukocytes by fine-needle aspiration cytology; a well-margined and homogeneous pattern on imaging; and a tumor location in the tail or preauricular area of the parotid gland. We reviewed 552 cases treated with parotid gland surgery in our hospital.

RESULTS

A total of 108 tumors were treated with enucleation and included no malignant solid tumors or pleomorphic adenoma. Enucleation demonstrated low invasiveness and complication rates. Revision surgery for WT reappearance after enucleation was rare and showed minimal scarring, with a lower risk of facial weakness.

CONCLUSIONS

The indication criteria for enucleation were validated. Such enucleation is useful, as it is associated with minimal invasiveness, low complication rates, and safety in revision surgery.

摘要

背景

剜除术已被报道为治疗沃辛瘤(Warthin's tumor,WT)的一种微创手术。然而,剜除术的明确适应证尚未明确。

方法

细针抽吸细胞学检查显示 WT、囊性液或良性白细胞、影像学表现为边界清楚且均匀的模式、肿瘤位于腮腺尾部或耳前区,满足这些发现即行剜除术。我们对我院 552 例腮腺手术治疗的病例进行了回顾性研究。

结果

共 108 例肿瘤行剜除术,其中无恶性实体瘤或多形性腺瘤。剜除术具有侵袭性小、并发症发生率低的特点。剜除术后 WT 复发的再次手术罕见,且瘢痕极小,面神经瘫痪风险低。

结论

验证了剜除术的适应证标准。这种剜除术具有微创、低并发症发生率和再次手术安全性的优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验